Psyence Biomedical Ltd. Common Shares (PBM) — Long-term Investment Intensity
Psyence Biomedical Ltd. Common Shares (PBM) has a Long-term Investment Intensity of 40.4% as of September 2025. Long-term investments of $5.17 Million represent 40.4% of total assets of $12.81 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Psyence Biomedical Ltd. Common Shares (PBM) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Psyence Biomedical Ltd. Common Shares Long-term Investment Intensity (2025–2025)
This chart shows how Psyence Biomedical Ltd. Common Shares's Long-term Investment Intensity has evolved across 1 annual periods from 2025 to 2025. As of September 2025, the intensity stands at 40.4%, reflecting long-term investments of $5.17 Million against total assets of $12.81 Million USD. For the complete balance sheet picture, see balance sheet size of Psyence Biomedical Ltd. Common Shares.
Annual Long-term Investment Intensity for Psyence Biomedical Ltd. Common Shares (2025–2025)
The table below presents the year-by-year Long-term Investment Intensity for Psyence Biomedical Ltd. Common Shares from 2025 to 2025, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read PBM current and long-term liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 10.2% | $745.00K | $7.32 Million | — |